相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis
Piyush Nathani et al.
GUT (2021)
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis
Jan Best et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Hepatocellular Carcinoma Demonstrates Heterogeneous Growth Patterns in a Multicenter Cohort of Patients With Cirrhosis
Nicole E. Rich et al.
HEPATOLOGY (2020)
Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial
Richard S. Finn et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma
Bruno Sangro et al.
JOURNAL OF HEPATOLOGY (2020)
Clinical utility of hepatocellular carcinoma risk scores in chronic hepatitis B
Thodoris Voulgaris et al.
LIVER INTERNATIONAL (2020)
Management of hepatocellular carcinoma in the time of COVID-19
M. Iavarone et al.
ANNALS OF ONCOLOGY (2020)
Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement
Oren K. Fix et al.
HEPATOLOGY (2020)
Ethics and Resource Scarcity: ASCO Recommendations for the Oncology Community During the COVID-19 Pandemic
Jonathan M. Marron et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The COVID-19 pandemic will have a long-lasting impact on the quality of cirrhosis care
Elliot B. Tapper et al.
JOURNAL OF HEPATOLOGY (2020)
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
Stephen M. Kissler et al.
SCIENCE (2020)
Suggestions for the care of patients with liver disease during the Coronavirus 2019 pandemic
Nathalie Ganne-Carrie et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Interventional oncology at the time of COVID-19 pandemic: Problems and solutions
A. Denys et al.
DIAGNOSTIC AND INTERVENTIONAL IMAGING (2020)
Streamlining radioembolization in UNOS T1/T2 hepatocellular carcinoma by eliminating lung shunt estimation
Ahmed Gabr et al.
JOURNAL OF HEPATOLOGY (2020)
Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification
George N. Ioannou et al.
JOURNAL OF HEPATOLOGY (2019)
Ramucirumab in advanced hepatocellular carcinoma in REACH-2: the true value of α-fetoprotein
Andrew X. Zhu et al.
LANCET ONCOLOGY (2019)
Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child-Pugh A Liver Function: A Proof-Of-Concept Study
Masatoshi Kudo et al.
CANCERS (2019)
Biology and significance of alpha-fetoprotein in hepatocellular carcinoma
Peter R. Galle et al.
LIVER INTERNATIONAL (2019)
Post-treatment alpha-fetoprotein response predicts prognosis of patients with hepatocellular carcinoma A meta-analysis
Chao He et al.
MEDICINE (2019)
Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis
Hooman Farhang Zangneh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients
Adam Doyle et al.
JOURNAL OF HEPATOLOGY (2019)
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2019)
Multicenter validation of a score to predict prognosis after the development of HCC recurrence following liver transplantation
Nicolas Goldaracena et al.
HPB (2019)
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma A Multicenter Study From China
Xin-Fei Xu et al.
JAMA SURGERY (2019)
Predictors of low risk for dropout from the liver transplant waiting list for hepatocellular carcinoma in long wait time regions: Implications for organ allocation
Neil Mehta et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Curative salvage liver transplantation in patients with cirrhosis and hepatocellular carcinoma: An intention-to-treat analysis
Robbert J. de Haas et al.
HEPATOLOGY (2018)
Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study
Ian Chau et al.
BRITISH JOURNAL OF CANCER (2018)
Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma
Vincenzo Mazzaferro et al.
GASTROENTEROLOGY (2018)
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
Kristina Tzartzeva et al.
GASTROENTEROLOGY (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
G. K. Abou-Alfa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection
Anthony W. H. Chan et al.
JOURNAL OF HEPATOLOGY (2018)
Liver Transplantation and Hepatic Resection can Achieve Cure for Hepatocellular Carcinoma
Antonio Daniele Pinna et al.
ANNALS OF SURGERY (2018)
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease
Fasiha Kanwal et al.
GASTROENTEROLOGY (2018)
Hepatocellular carcinoma surgical therapy: perspectives on the current limits to resection
Akhil Chawla et al.
CHINESE CLINICAL ONCOLOGY (2018)
Validation of the prognostic power of the RETREAT score for hepatocellular carcinoma recurrence using the UNOS database
Neil Mehta et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
A Bayesian screening approach for hepatocellular carcinoma using multiple longitudinal biomarkers
Nabihah Tayob et al.
BIOMETRICS (2018)
Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis
O. Simmons et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Patient-Reported Barriers Are Associated With Lower Hepatocellular Carcinoma Surveillance Rates in Patients With Cirrhosis
Sherean Farvardin et al.
HEPATOLOGY (2017)
Intention-to-Treat Survival Benefit of Liver Transplantation in Patients With Hepatocellular Cancer
Quirino Lai et al.
HEPATOLOGY (2017)
NCCN Guidelines® Insights Hepatobiliary Cancers, Version 1.2017 Featured Updates to the NCCN Guidelines
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2017)
Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic Malignancy
Ron C. Gaba et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2017)
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
Jordi Bruix et al.
LANCET (2017)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant
Neil Mehta et al.
JAMA ONCOLOGY (2017)
Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase
Ju Dong Yang et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Recurrence After Liver Transplantation for Hepatocellular Carcinoma A New MORAL to the Story
Karim J. Halazun et al.
ANNALS OF SURGERY (2017)
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients
Sarah Berhane et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2016)
Clinical and Imaging Follow-up Practices after Transarterial Therapy for Primary and Secondary Hepatic Malignancies: Results of an Online Survey
Ron C. Gaba et al.
ACADEMIC RADIOLOGY (2015)
A Novel Prognostic Nomogram Accurately Predicts Hepatocellular Carcinoma Recurrence after Liver Transplantation: Analysis of 865 Consecutive Liver Transplant Recipients
Vatche G. Agopian et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2015)
Optimal Imaging Surveillance Schedules after Liver-Directed Therapy for Hepatocellular Carcinoma
F. Edward Boas et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2015)
The Time Course of Dynamic Computed Tomographic Appearance of Radiation Injury to the Cirrhotic Liver Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
Tomoki Kimura et al.
PLOS ONE (2015)
Risk Prediction of Hepatocellular Carcinoma in Patients With Cirrhosis: The ADRESS-HCC Risk Model
Jennifer A. Flemming et al.
CANCER (2014)
Factors That Affect Accuracy of α-Fetoprotein Test in Detection of Hepatocellular Carcinoma in Patients With Cirrhosis
Purva Gopal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Predicting recurrence patterns after resection of hepatocellular cancer
Ser Yee Lee et al.
HPB (2014)
Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
Amit G. Singal et al.
PLOS MEDICINE (2014)
Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis
Khairuddin Memon et al.
JOURNAL OF HEPATOLOGY (2012)
A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma
Kai Feng et al.
JOURNAL OF HEPATOLOGY (2012)
Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma
Jing-Houng Wang et al.
JOURNAL OF HEPATOLOGY (2012)
Efficacy, Safety, and Biomarkers of Single- Agent Bevacizumab Therapy in Patients with Advanced Hepatocellular Carcinoma
Valerie Boige et al.
ONCOLOGIST (2012)
Ultrasonographic Surveillance of Hepatocellular Carcinoma in Cirrhosis: A Randomized Trial Comparing 3-and 6-Month Periodicities
Jean-Claude Trinchet et al.
HEPATOLOGY (2011)
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
Hwai-I Yang et al.
LANCET ONCOLOGY (2011)
Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival
Valentina Santi et al.
JOURNAL OF HEPATOLOGY (2010)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinoma
Abby B. Siegel et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Multimodality imaging following Y-90 radioembolization: A comprehensive review and pictorial essay
Bassel Atassi et al.
RADIOGRAPHICS (2008)
Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis
S Roayaie et al.
LIVER TRANSPLANTATION (2004)
Randomized controlled trial of screening for hepatocellular carcinoma
BH Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
分享论文
